ECO Animal Health Group plc (AIM:EAH)
London · Delayed Price · Currency is GBP · Price in GBX 79.20
+1.70 (2.19%)
Jul 30, 2025, 9:31 AM GMT+1
ECO Animal Health Group Company Description
ECO Animal Health Group plc, together with its subsidiaries, develops, registers, and markets pharmaceutical products for animals worldwide.
The company provides Aivlosin, a macrolide antibiotic for the treatment of enteric and respiratory diseases in pigs and poultry.
It also offers generic drugs, such as Ecomectin, Ecoheart, Ecotraz, and Ecomintic, which are endectocides and other antiparasitics for the treatment and prevention of parasites, such as worms, ticks, lices, and mange in cattle, sheep, pigs, horses, and dogs; and Chlortetracycline and Oxytetracycline for treatment of bacterial infections in pigs, poultry, and cattle.
ECO Animal Health Group plc was founded in 1972 and is based in London, the United Kingdom.
ECO Animal Health Group plc
| Country | United Kingdom |
| Founded | 1972 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 224 |
| CEO | David Hallas |
Contact Details
Address: The Grange London, N14 6BN United Kingdom | |
| Phone | 44 208 447 8899 |
| Website | ecoanimalhealth.com |
Stock Details
| Ticker Symbol | EAH |
| Exchange | London Stock Exchange AIM |
| Fiscal Year | April - March |
| Reporting Currency | GBP |
| ISIN Number | GB0032036807 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| David Hallas | Chief Executive Officer |
| Christopher Wilks | Chief Financial Officer |